

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 8.47697957 |
| 2 | negative regulation of cell killing (GO:0031342) | 8.47697957 |
| 3 | response to interleukin-15 (GO:0070672) | 7.95116824 |
| 4 | negative T cell selection (GO:0043383) | 7.74298530 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 7.67546834 |
| 6 | negative thymic T cell selection (GO:0045060) | 7.59478125 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.24985357 |
| 8 | positive thymic T cell selection (GO:0045059) | 6.99190805 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.96272028 |
| 10 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.83850293 |
| 11 | tolerance induction (GO:0002507) | 6.74506032 |
| 12 | positive T cell selection (GO:0043368) | 6.66233832 |
| 13 | thymic T cell selection (GO:0045061) | 6.59127930 |
| 14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.42242015 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 6.22585193 |
| 16 | T cell selection (GO:0045058) | 6.20511573 |
| 17 | interferon-gamma production (GO:0032609) | 6.08027777 |
| 18 | regulation of T cell tolerance induction (GO:0002664) | 5.79493651 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.49072705 |
| 20 | T cell receptor signaling pathway (GO:0050852) | 5.36706122 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.34852079 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.34852079 |
| 23 | T cell migration (GO:0072678) | 5.34187910 |
| 24 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.19874765 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.08472995 |
| 26 | T cell costimulation (GO:0031295) | 4.98165877 |
| 27 | positive regulation of tolerance induction (GO:0002645) | 4.93737003 |
| 28 | lymphocyte costimulation (GO:0031294) | 4.91641393 |
| 29 | leukocyte aggregation (GO:0070486) | 4.75296875 |
| 30 | regulation of regulatory T cell differentiation (GO:0045589) | 4.61431881 |
| 31 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.45294906 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 4.42929483 |
| 33 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.40560186 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.28822291 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27042785 |
| 36 | regulation of tolerance induction (GO:0002643) | 4.22986964 |
| 37 | positive regulation of T cell differentiation in thymus (GO:0033089) | 4.14699417 |
| 38 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.12027262 |
| 39 | positive regulation of interleukin-2 production (GO:0032743) | 4.11842871 |
| 40 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.09997421 |
| 41 | alpha-beta T cell differentiation (GO:0046632) | 3.93326953 |
| 42 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.86227256 |
| 43 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.86227256 |
| 44 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.83441743 |
| 45 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.83441743 |
| 46 | regulation of isotype switching (GO:0045191) | 3.82557152 |
| 47 | T-helper cell differentiation (GO:0042093) | 3.81674077 |
| 48 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.81674077 |
| 49 | alpha-beta T cell activation (GO:0046631) | 3.80291541 |
| 50 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.77494153 |
| 51 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.75790591 |
| 52 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.75021112 |
| 53 | T cell differentiation (GO:0030217) | 3.74581203 |
| 54 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.70200702 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.68267333 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.67533669 |
| 57 | regulation of response to interferon-gamma (GO:0060330) | 3.67154667 |
| 58 | activated T cell proliferation (GO:0050798) | 3.66021035 |
| 59 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.65154681 |
| 60 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.64331928 |
| 61 | mast cell activation (GO:0045576) | 3.63121912 |
| 62 | positive regulation of isotype switching (GO:0045830) | 3.62077881 |
| 63 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.57997554 |
| 64 | regulation of chronic inflammatory response (GO:0002676) | 3.49203533 |
| 65 | regulation of interleukin-2 production (GO:0032663) | 3.47057181 |
| 66 | regulation of cell killing (GO:0031341) | 3.44736459 |
| 67 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.44249525 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41578507 |
| 69 | mast cell degranulation (GO:0043303) | 3.41492767 |
| 70 | mast cell activation involved in immune response (GO:0002279) | 3.41492767 |
| 71 | T cell differentiation involved in immune response (GO:0002292) | 3.39707476 |
| 72 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.39707476 |
| 73 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.39707476 |
| 74 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.39139444 |
| 75 | positive regulation of humoral immune response (GO:0002922) | 3.39043252 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.35875744 |
| 77 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.33863169 |
| 78 | regulation of B cell mediated immunity (GO:0002712) | 3.30852393 |
| 79 | positive regulation of granulocyte differentiation (GO:0030854) | 3.30499909 |
| 80 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.30161244 |
| 81 | response to muramyl dipeptide (GO:0032495) | 3.29507873 |
| 82 | T cell activation (GO:0042110) | 3.26652232 |
| 83 | negative regulation of innate immune response (GO:0045824) | 3.25883150 |
| 84 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25357579 |
| 85 | regulation of defense response to virus by virus (GO:0050690) | 3.24916566 |
| 86 | positive regulation of cell killing (GO:0031343) | 3.23257238 |
| 87 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.22949170 |
| 88 | positive regulation of B cell mediated immunity (GO:0002714) | 3.22949170 |
| 89 | lymph node development (GO:0048535) | 3.22174263 |
| 90 | regulation of memory T cell differentiation (GO:0043380) | 3.22017575 |
| 91 | T cell homeostasis (GO:0043029) | 3.21823431 |
| 92 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.16819071 |
| 93 | natural killer cell activation (GO:0030101) | 3.16524684 |
| 94 | regulation of immunoglobulin production (GO:0002637) | 3.15358984 |
| 95 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.13932287 |
| 96 | Peyers patch development (GO:0048541) | 3.13932287 |
| 97 | positive regulation of DNA recombination (GO:0045911) | 3.12549805 |
| 98 | lymphocyte migration (GO:0072676) | 3.12283143 |
| 99 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.12186904 |
| 100 | positive regulation of T cell differentiation (GO:0045582) | 3.11927410 |
| 101 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11294436 |
| 102 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.10969229 |
| 103 | mature B cell differentiation (GO:0002335) | 3.10027776 |
| 104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.08990991 |
| 105 | regulation of T cell mediated immunity (GO:0002709) | 3.08894116 |
| 106 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.08240073 |
| 107 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.08234028 |
| 108 | RNA destabilization (GO:0050779) | 3.06331080 |
| 109 | positive regulation of T cell activation (GO:0050870) | 3.06083527 |
| 110 | positive regulation of defense response to virus by host (GO:0002230) | 3.01453657 |
| 111 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98955945 |
| 112 | positive regulation of T cell mediated immunity (GO:0002711) | 2.93906885 |
| 113 | regulation of alpha-beta T cell activation (GO:0046634) | 2.85562534 |
| 114 | positive regulation of interleukin-4 production (GO:0032753) | 2.84737697 |
| 115 | negative regulation of adaptive immune response (GO:0002820) | 2.83347404 |
| 116 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80780859 |
| 117 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80296746 |
| 118 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80296746 |
| 119 | lymphocyte homeostasis (GO:0002260) | 2.75683067 |
| 120 | regulation of defense response to virus by host (GO:0050691) | 2.71058161 |
| 121 | dendritic cell chemotaxis (GO:0002407) | 2.70019438 |
| 122 | regulation of interleukin-4 production (GO:0032673) | 2.69711161 |
| 123 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.68641426 |
| 124 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.68589617 |
| 125 | regulation of T cell cytokine production (GO:0002724) | 2.68433832 |
| 126 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.66328313 |
| 127 | negative regulation of interleukin-10 production (GO:0032693) | 2.64491242 |
| 128 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.62740503 |
| 129 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.62713200 |
| 130 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.62655712 |
| 131 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.61098215 |
| 132 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.58884882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.87096108 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.64812683 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.42530835 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.22744541 |
| 5 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.96728218 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.89970679 |
| 7 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.66913262 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.36509499 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.34199592 |
| 10 | MAF_26560356_Chip-Seq_TH1_Human | 3.21107725 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.03008890 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.00738666 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98272880 |
| 14 | MYB_26560356_Chip-Seq_TH1_Human | 2.94942977 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.86892317 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.86433060 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78131446 |
| 18 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.46003379 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.41000528 |
| 20 | * MAF_26560356_Chip-Seq_TH2_Human | 2.29346287 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.29192608 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.29097343 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28024909 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27144583 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.23480483 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.23218755 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.21943715 |
| 28 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.07998880 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.04477889 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01222310 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01032147 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.99576561 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98925504 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96608751 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.79631919 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78658485 |
| 37 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.78533397 |
| 38 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.78155543 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71769624 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61714980 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60740234 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54334983 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51829678 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47348331 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45975917 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45833777 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45647350 |
| 48 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45296600 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45001657 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42848278 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42351916 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.42176790 |
| 53 | P68_20966046_ChIP-Seq_HELA_Human | 1.37729935 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35611128 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30525436 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29751305 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28055470 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27753810 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22385609 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21521134 |
| 61 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20684325 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16019658 |
| 63 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14069875 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10502152 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09361347 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08163045 |
| 67 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08054942 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06795466 |
| 69 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.05420892 |
| 70 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.04067575 |
| 71 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03886767 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03782252 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03399417 |
| 74 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02851916 |
| 75 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01678975 |
| 76 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00652045 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99345467 |
| 78 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98089440 |
| 79 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.97991088 |
| 80 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.97048394 |
| 81 | * P300_27268052_Chip-Seq_Bcells_Human | 0.96588302 |
| 82 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.96132141 |
| 83 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95815157 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94208605 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92094794 |
| 86 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91929217 |
| 87 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91460510 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91223429 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90507499 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90422391 |
| 91 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89161966 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88388504 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87174077 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86193544 |
| 95 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.85781469 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85454600 |
| 97 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85345666 |
| 98 | ERA_21632823_ChIP-Seq_H3396_Human | 0.85231342 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85182405 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85000422 |
| 101 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.84730175 |
| 102 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.84691192 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83155657 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82923299 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82830231 |
| 106 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82741528 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82418404 |
| 108 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.81628498 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81139267 |
| 110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80354291 |
| 111 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.80173417 |
| 112 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.79849817 |
| 113 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.78817823 |
| 114 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.78784812 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78450000 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78343166 |
| 117 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77279612 |
| 118 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76456462 |
| 119 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.74426090 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.73918748 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.73736774 |
| 122 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.73706115 |
| 123 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.73682874 |
| 124 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73005977 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72557583 |
| 126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71880372 |
| 127 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70700765 |
| 128 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.69531829 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69478830 |
| 130 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69035788 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67049946 |
| 132 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.66577245 |
| 133 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.65873011 |
| 134 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.65761454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.21521043 |
| 2 | MP0005671_abnormal_response_to | 4.58919034 |
| 3 | MP0000685_abnormal_immune_system | 3.93516238 |
| 4 | MP0001800_abnormal_humoral_immune | 3.24358311 |
| 5 | MP0001790_abnormal_immune_system | 3.06200639 |
| 6 | MP0005387_immune_system_phenotype | 3.06200639 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.96939238 |
| 8 | MP0002723_abnormal_immune_serum | 2.89455442 |
| 9 | * MP0002420_abnormal_adaptive_immunity | 2.79669115 |
| 10 | * MP0002398_abnormal_bone_marrow | 2.77061038 |
| 11 | * MP0001819_abnormal_immune_cell | 2.75236971 |
| 12 | MP0001873_stomach_inflammation | 2.74635341 |
| 13 | MP0002405_respiratory_system_inflammati | 2.70858431 |
| 14 | * MP0000703_abnormal_thymus_morphology | 2.69904567 |
| 15 | MP0003866_abnormal_defecation | 2.69509485 |
| 16 | MP0003724_increased_susceptibility_to | 2.66740589 |
| 17 | MP0004510_myositis | 2.58898585 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.55761767 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.52880505 |
| 20 | MP0009785_altered_susceptibility_to | 2.47273422 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.47084472 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.44772910 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.41845436 |
| 24 | * MP0000716_abnormal_immune_system | 2.38762149 |
| 25 | MP0003436_decreased_susceptibility_to | 2.36744041 |
| 26 | MP0002933_joint_inflammation | 2.32823212 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.26348952 |
| 28 | * MP0002722_abnormal_immune_system | 2.26255252 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.12505118 |
| 30 | MP0005025_abnormal_response_to | 2.05898450 |
| 31 | MP0003300_gastrointestinal_ulcer | 2.01058035 |
| 32 | MP0004947_skin_inflammation | 1.98071829 |
| 33 | * MP0002429_abnormal_blood_cell | 1.92881189 |
| 34 | MP0002006_tumorigenesis | 1.88102523 |
| 35 | MP0002822_catalepsy | 1.87989367 |
| 36 | MP0006082_CNS_inflammation | 1.76539279 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 1.73845956 |
| 38 | MP0003303_peritoneal_inflammation | 1.69214289 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.68893026 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.67632467 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.60205773 |
| 42 | MP0002419_abnormal_innate_immunity | 1.58491591 |
| 43 | MP0004885_abnormal_endolymph | 1.57870220 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.57670678 |
| 45 | MP0004130_abnormal_muscle_cell | 1.56434043 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.56372361 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.55868215 |
| 48 | MP0004742_abnormal_vestibular_system | 1.38158636 |
| 49 | MP0004381_abnormal_hair_follicle | 1.37241269 |
| 50 | MP0001853_heart_inflammation | 1.36750620 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.31285909 |
| 52 | MP0001851_eye_inflammation | 1.27957676 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.27775144 |
| 54 | MP0003879_abnormal_hair_cell | 1.26542649 |
| 55 | MP0001968_abnormal_touch/_nociception | 1.23189051 |
| 56 | MP0000858_altered_metastatic_potential | 1.13859393 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.11252463 |
| 58 | MP0005310_abnormal_salivary_gland | 1.11217116 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.07880806 |
| 60 | MP0008872_abnormal_physiological_respon | 1.07114537 |
| 61 | MP0002272_abnormal_nervous_system | 1.02050083 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.01573931 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.01236894 |
| 64 | MP0003880_abnormal_central_pattern | 1.01107879 |
| 65 | MP0002064_seizures | 1.00881085 |
| 66 | MP0000490_abnormal_crypts_of | 0.99604015 |
| 67 | MP0008569_lethality_at_weaning | 0.94403422 |
| 68 | MP0004142_abnormal_muscle_tone | 0.93171517 |
| 69 | MP0008469_abnormal_protein_level | 0.93076149 |
| 70 | MP0002063_abnormal_learning/memory/cond | 0.91836356 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.90699117 |
| 72 | MP0002653_abnormal_ependyma_morphology | 0.85314715 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.84922843 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 0.84922843 |
| 75 | MP0001486_abnormal_startle_reflex | 0.84436357 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.81504605 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.81387973 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.80968768 |
| 79 | MP0001919_abnormal_reproductive_system | 0.80513515 |
| 80 | MP0000604_amyloidosis | 0.80422206 |
| 81 | MP0002163_abnormal_gland_morphology | 0.79070430 |
| 82 | MP0002928_abnormal_bile_duct | 0.78528428 |
| 83 | MP0003045_fibrosis | 0.76959935 |
| 84 | MP0002254_reproductive_system_inflammat | 0.75735296 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 0.75420538 |
| 86 | MP0003646_muscle_fatigue | 0.74897954 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.73455623 |
| 88 | MP0005390_skeleton_phenotype | 0.73432318 |
| 89 | MP0003787_abnormal_imprinting | 0.70347163 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.69011152 |
| 91 | MP0003448_altered_tumor_morphology | 0.67650357 |
| 92 | MP0001970_abnormal_pain_threshold | 0.67558930 |
| 93 | MP0001440_abnormal_grooming_behavior | 0.66526529 |
| 94 | MP0002019_abnormal_tumor_incidence | 0.64148483 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.64098248 |
| 96 | MP0003828_pulmonary_edema | 0.63861597 |
| 97 | MP0002067_abnormal_sensory_capabilities | 0.63579017 |
| 98 | MP0008877_abnormal_DNA_methylation | 0.62512925 |
| 99 | MP0009764_decreased_sensitivity_to | 0.62051717 |
| 100 | MP0005535_abnormal_body_temperature | 0.61258766 |
| 101 | MP0000609_abnormal_liver_physiology | 0.60034518 |
| 102 | MP0005076_abnormal_cell_differentiation | 0.59492250 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.59107580 |
| 104 | MP0002733_abnormal_thermal_nociception | 0.59038350 |
| 105 | MP0003091_abnormal_cell_migration | 0.58966971 |
| 106 | MP0005381_digestive/alimentary_phenotyp | 0.58633642 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.58434848 |
| 108 | MP0003279_aneurysm | 0.58053122 |
| 109 | MP0009278_abnormal_bone_marrow | 0.57980712 |
| 110 | MP0002132_abnormal_respiratory_system | 0.57096697 |
| 111 | MP0001663_abnormal_digestive_system | 0.56751651 |
| 112 | MP0005670_abnormal_white_adipose | 0.56456176 |
| 113 | MP0009763_increased_sensitivity_to | 0.55751510 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 0.55043822 |
| 115 | MP0000477_abnormal_intestine_morphology | 0.54927587 |
| 116 | MP0005377_hearing/vestibular/ear_phenot | 0.53612366 |
| 117 | MP0003878_abnormal_ear_physiology | 0.53612366 |
| 118 | MP0005165_increased_susceptibility_to | 0.53573622 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.51655353 |
| 120 | MP0003329_amyloid_beta_deposits | 0.51372208 |
| 121 | MP0002009_preneoplasia | 0.51357389 |
| 122 | MP0005023_abnormal_wound_healing | 0.51340302 |
| 123 | MP0008770_decreased_survivor_rate | 0.50573901 |
| 124 | MP0010352_gastrointestinal_tract_polyps | 0.50399716 |
| 125 | MP0005423_abnormal_somatic_nervous | 0.50240890 |
| 126 | MP0001881_abnormal_mammary_gland | 0.48845443 |
| 127 | MP0003075_altered_response_to | 0.48694499 |
| 128 | MP0001502_abnormal_circadian_rhythm | 0.47644379 |
| 129 | MP0000249_abnormal_blood_vessel | 0.47094549 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.45064901 |
| 131 | MP0002083_premature_death | 0.44299719 |
| 132 | MP0005174_abnormal_tail_pigmentation | 0.43799723 |
| 133 | MP0009745_abnormal_behavioral_response | 0.41987527 |
| 134 | MP0008007_abnormal_cellular_replicative | 0.41357401 |
| 135 | MP0000343_altered_response_to | 0.40332399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.49537963 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.08086811 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 5.79179927 |
| 4 | Abnormality of T cells (HP:0002843) | 5.63153861 |
| 5 | Stomatitis (HP:0010280) | 5.33477818 |
| 6 | Combined immunodeficiency (HP:0005387) | 5.22753852 |
| 7 | IgM deficiency (HP:0002850) | 5.06965980 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.98563151 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.92725155 |
| 10 | Myositis (HP:0100614) | 4.72713720 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 4.65984637 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.65984637 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.56676039 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.50705618 |
| 15 | Chronic diarrhea (HP:0002028) | 4.32983724 |
| 16 | IgG deficiency (HP:0004315) | 4.24058590 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.15891430 |
| 18 | Nasal polyposis (HP:0100582) | 4.15567613 |
| 19 | Papilledema (HP:0001085) | 3.99997084 |
| 20 | Optic neuritis (HP:0100653) | 3.95224211 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.95224211 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.89580726 |
| 23 | Chronic otitis media (HP:0000389) | 3.80794125 |
| 24 | Abnormality of eosinophils (HP:0001879) | 3.71206783 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.65593220 |
| 26 | Orchitis (HP:0100796) | 3.64874359 |
| 27 | Increased density of long bones (HP:0006392) | 3.59964818 |
| 28 | Abnormality of the nasal mucosa (HP:0000433) | 3.56890717 |
| 29 | Recurrent viral infections (HP:0004429) | 3.50289154 |
| 30 | Joint swelling (HP:0001386) | 3.48648713 |
| 31 | Stomach cancer (HP:0012126) | 3.47865586 |
| 32 | Keratoconjunctivitis sicca (HP:0001097) | 3.42894156 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.40062108 |
| 34 | Thyroiditis (HP:0100646) | 3.38456024 |
| 35 | IgA deficiency (HP:0002720) | 3.36389607 |
| 36 | Pustule (HP:0200039) | 3.34031177 |
| 37 | Hemoptysis (HP:0002105) | 3.28970287 |
| 38 | Abnormality of B cell number (HP:0010975) | 3.22321389 |
| 39 | B lymphocytopenia (HP:0010976) | 3.22321389 |
| 40 | Lymphopenia (HP:0001888) | 3.19253297 |
| 41 | Eczematoid dermatitis (HP:0000976) | 3.15058961 |
| 42 | Abnormality of the fingertips (HP:0001211) | 3.09013815 |
| 43 | Keratoconjunctivitis (HP:0001096) | 3.05521599 |
| 44 | Leukocytosis (HP:0001974) | 3.03006348 |
| 45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.02956774 |
| 46 | Persistence of primary teeth (HP:0006335) | 2.95929508 |
| 47 | Increased IgM level (HP:0003496) | 2.94841259 |
| 48 | Basal cell carcinoma (HP:0002671) | 2.82608847 |
| 49 | Increased IgE level (HP:0003212) | 2.71268056 |
| 50 | Hemiplegia (HP:0002301) | 2.70845414 |
| 51 | Recurrent sinusitis (HP:0011108) | 2.68375692 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.65224978 |
| 53 | Bronchitis (HP:0012387) | 2.63600737 |
| 54 | Arterial thrombosis (HP:0004420) | 2.63549005 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.58744459 |
| 56 | Encephalitis (HP:0002383) | 2.57917597 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.55707211 |
| 58 | Vasculitis (HP:0002633) | 2.54331231 |
| 59 | Genetic anticipation (HP:0003743) | 2.52909317 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.52143339 |
| 61 | Eosinophilia (HP:0001880) | 2.49166443 |
| 62 | Obstructive sleep apnea (HP:0002870) | 2.48489208 |
| 63 | Cheilitis (HP:0100825) | 2.46605752 |
| 64 | Meningitis (HP:0001287) | 2.37155864 |
| 65 | Hypoplasia of the thymus (HP:0000778) | 2.33299918 |
| 66 | Hypochromic anemia (HP:0001931) | 2.32530650 |
| 67 | Abnormality of binocular vision (HP:0011514) | 2.31622449 |
| 68 | Diplopia (HP:0000651) | 2.31622449 |
| 69 | Progressive cerebellar ataxia (HP:0002073) | 2.29928571 |
| 70 | Congenital stationary night blindness (HP:0007642) | 2.29621289 |
| 71 | Recurrent bacterial skin infections (HP:0005406) | 2.26847718 |
| 72 | Granulocytopenia (HP:0001913) | 2.25131555 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.25033309 |
| 74 | Ureteral stenosis (HP:0000071) | 2.20085575 |
| 75 | Lymphoma (HP:0002665) | 2.19814564 |
| 76 | Chest pain (HP:0100749) | 2.18340947 |
| 77 | Pulmonary embolism (HP:0002204) | 2.17231111 |
| 78 | Premature loss of primary teeth (HP:0006323) | 2.17149423 |
| 79 | Clumsiness (HP:0002312) | 2.14851092 |
| 80 | Type II lissencephaly (HP:0007260) | 2.14743933 |
| 81 | Prolonged bleeding time (HP:0003010) | 2.12887182 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.11562644 |
| 83 | Agammaglobulinemia (HP:0004432) | 2.09833691 |
| 84 | Visual hallucinations (HP:0002367) | 2.09480683 |
| 85 | Asplenia (HP:0001746) | 2.08709956 |
| 86 | Alveolar cell carcinoma (HP:0006519) | 2.07537593 |
| 87 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.06644241 |
| 88 | Recurrent skin infections (HP:0001581) | 2.05226100 |
| 89 | Abnormal platelet volume (HP:0011876) | 2.04704193 |
| 90 | Chronic sinusitis (HP:0011109) | 1.99934717 |
| 91 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.98647920 |
| 92 | Thrombocytosis (HP:0001894) | 1.97868321 |
| 93 | Recurrent otitis media (HP:0000403) | 1.96197180 |
| 94 | Abnormality of the endocardium (HP:0004306) | 1.95855124 |
| 95 | Abnormality of the lower motor neuron (HP:0002366) | 1.95417537 |
| 96 | Bicuspid aortic valve (HP:0001647) | 1.94877663 |
| 97 | Recurrent abscess formation (HP:0002722) | 1.94181626 |
| 98 | Ureteral obstruction (HP:0006000) | 1.93581710 |
| 99 | Emphysema (HP:0002097) | 1.93427285 |
| 100 | Epistaxis (HP:0000421) | 1.93238361 |
| 101 | Conical tooth (HP:0000698) | 1.89679536 |
| 102 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.84716143 |
| 103 | Hepatitis (HP:0012115) | 1.84559342 |
| 104 | Autoimmune thrombocytopenia (HP:0001973) | 1.83158750 |
| 105 | Acrocyanosis (HP:0001063) | 1.82926378 |
| 106 | Annular pancreas (HP:0001734) | 1.82188468 |
| 107 | Colitis (HP:0002583) | 1.80970176 |
| 108 | Metabolic alkalosis (HP:0200114) | 1.80023861 |
| 109 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79472408 |
| 110 | Verrucae (HP:0200043) | 1.78830749 |
| 111 | Papilloma (HP:0012740) | 1.78830749 |
| 112 | Hematochezia (HP:0002573) | 1.76838621 |
| 113 | Abnormality of the pleura (HP:0002103) | 1.76553248 |
| 114 | Decreased circulating renin level (HP:0003351) | 1.76243229 |
| 115 | Broad palm (HP:0001169) | 1.75969155 |
| 116 | Keratitis (HP:0000491) | 1.74544377 |
| 117 | Dyskinesia (HP:0100660) | 1.73838986 |
| 118 | Bronchiectasis (HP:0002110) | 1.73560338 |
| 119 | Hyperlipoproteinemia (HP:0010980) | 1.72233589 |
| 120 | Hypochromic microcytic anemia (HP:0004840) | 1.70278499 |
| 121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69632183 |
| 122 | Arthralgia (HP:0002829) | 1.68962273 |
| 123 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.68699196 |
| 124 | Chronic obstructive pulmonary disease (HP:0006510) | 1.68614979 |
| 125 | Obstructive lung disease (HP:0006536) | 1.68614979 |
| 126 | Anorexia (HP:0002039) | 1.67970039 |
| 127 | Abnormality of the columella (HP:0009929) | 1.67773416 |
| 128 | Spinal canal stenosis (HP:0003416) | 1.67342408 |
| 129 | Gastrointestinal stroma tumor (HP:0100723) | 1.67148659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.33508835 |
| 2 | MAP4K1 | 5.57092304 |
| 3 | ITK | 3.21108056 |
| 4 | JAK3 | 3.14599284 |
| 5 | ZAP70 | 3.10011112 |
| 6 | JAK1 | 2.61866602 |
| 7 | FGFR4 | 2.60910850 |
| 8 | MAP3K14 | 2.42921850 |
| 9 | NLK | 2.37886660 |
| 10 | CAMKK1 | 2.35220171 |
| 11 | IKBKE | 2.31554827 |
| 12 | TYK2 | 2.20438523 |
| 13 | GRK6 | 2.15980553 |
| 14 | MAP3K13 | 2.07428973 |
| 15 | STK10 | 2.00542708 |
| 16 | CAMKK2 | 1.94828028 |
| 17 | LCK | 1.88976945 |
| 18 | PASK | 1.88443872 |
| 19 | TEC | 1.86467377 |
| 20 | EEF2K | 1.83023154 |
| 21 | MAP2K2 | 1.78258886 |
| 22 | RIPK4 | 1.62792576 |
| 23 | KDR | 1.59150669 |
| 24 | SIK2 | 1.56973249 |
| 25 | TBK1 | 1.53974567 |
| 26 | HCK | 1.49433050 |
| 27 | TNIK | 1.48900808 |
| 28 | FGFR3 | 1.44926675 |
| 29 | CLK1 | 1.41866018 |
| 30 | MAP3K7 | 1.37516700 |
| 31 | IRAK3 | 1.31345530 |
| 32 | SYK | 1.30905353 |
| 33 | PRKCH | 1.22617245 |
| 34 | PRKCQ | 1.21547452 |
| 35 | IKBKB | 1.17765864 |
| 36 | FES | 1.16027503 |
| 37 | MARK2 | 1.15127485 |
| 38 | CSK | 1.13461663 |
| 39 | BTK | 1.09623814 |
| 40 | EPHA3 | 1.05082606 |
| 41 | PKN2 | 1.04826529 |
| 42 | TAOK3 | 1.03556069 |
| 43 | EPHB1 | 1.01240326 |
| 44 | MAP3K12 | 1.01118672 |
| 45 | TLK1 | 0.99174843 |
| 46 | TGFBR2 | 0.98986730 |
| 47 | MAPK15 | 0.98084229 |
| 48 | MARK3 | 0.97982303 |
| 49 | JAK2 | 0.97854917 |
| 50 | CHUK | 0.97050664 |
| 51 | TAOK1 | 0.96571400 |
| 52 | BRD4 | 0.96014517 |
| 53 | SIK3 | 0.87865557 |
| 54 | MAP3K10 | 0.87661541 |
| 55 | CDK12 | 0.87637876 |
| 56 | TRIB3 | 0.86935310 |
| 57 | TNK2 | 0.86611394 |
| 58 | IRAK4 | 0.85907994 |
| 59 | TYRO3 | 0.85056541 |
| 60 | TSSK6 | 0.82209767 |
| 61 | PIM1 | 0.79841985 |
| 62 | ADRBK2 | 0.76288669 |
| 63 | PDGFRB | 0.75529552 |
| 64 | CDC42BPA | 0.73998753 |
| 65 | BLK | 0.73436774 |
| 66 | MAP3K11 | 0.69519814 |
| 67 | MAP2K3 | 0.69307630 |
| 68 | PRKD2 | 0.66833004 |
| 69 | KIT | 0.66259416 |
| 70 | MAPK13 | 0.65145286 |
| 71 | DAPK2 | 0.64044606 |
| 72 | TTN | 0.63530224 |
| 73 | FGFR2 | 0.63185056 |
| 74 | FGFR1 | 0.62646898 |
| 75 | LYN | 0.61683267 |
| 76 | PINK1 | 0.60881520 |
| 77 | UHMK1 | 0.60673872 |
| 78 | PRPF4B | 0.59795992 |
| 79 | RPS6KA6 | 0.59581417 |
| 80 | ALK | 0.59117832 |
| 81 | INSR | 0.55927429 |
| 82 | IGF1R | 0.55043016 |
| 83 | STK38 | 0.54941352 |
| 84 | MUSK | 0.54712768 |
| 85 | SIK1 | 0.54583955 |
| 86 | INSRR | 0.53881011 |
| 87 | CAMK4 | 0.52579182 |
| 88 | FYN | 0.52405324 |
| 89 | ERN1 | 0.52189835 |
| 90 | DYRK1B | 0.51611691 |
| 91 | NEK6 | 0.50095138 |
| 92 | DMPK | 0.49955720 |
| 93 | TESK2 | 0.49228394 |
| 94 | PDK1 | 0.48685539 |
| 95 | TAOK2 | 0.47164435 |
| 96 | RPS6KL1 | 0.47110566 |
| 97 | RPS6KC1 | 0.47110566 |
| 98 | RPS6KA4 | 0.47058959 |
| 99 | MAP4K2 | 0.46623271 |
| 100 | NTRK2 | 0.46365199 |
| 101 | GRK1 | 0.45239756 |
| 102 | CSF1R | 0.44116969 |
| 103 | GRK5 | 0.43990508 |
| 104 | RPS6KA2 | 0.43550124 |
| 105 | CDK4 | 0.41871531 |
| 106 | NTRK3 | 0.41566654 |
| 107 | LRRK2 | 0.41245372 |
| 108 | MAPK12 | 0.41160301 |
| 109 | SGK223 | 0.40062691 |
| 110 | SGK494 | 0.40062691 |
| 111 | RAF1 | 0.39451168 |
| 112 | MST4 | 0.38577080 |
| 113 | MAPK4 | 0.36855568 |
| 114 | EPHA4 | 0.35186282 |
| 115 | PTK2B | 0.34734100 |
| 116 | PTK6 | 0.34167962 |
| 117 | IRAK1 | 0.32349084 |
| 118 | PAK6 | 0.31948748 |
| 119 | RET | 0.31799117 |
| 120 | HIPK2 | 0.31514865 |
| 121 | DAPK1 | 0.29239704 |
| 122 | MAPK7 | 0.27432987 |
| 123 | CAMK1 | 0.22708352 |
| 124 | TIE1 | 0.19665806 |
| 125 | STK11 | 0.18852512 |
| 126 | SRC | 0.18787649 |
| 127 | MAPK3 | 0.18770365 |
| 128 | PTK2 | 0.18561534 |
| 129 | MAPK8 | 0.18301948 |
| 130 | MAPK11 | 0.18170308 |
| 131 | MAP3K1 | 0.17853406 |
| 132 | CDK9 | 0.16815340 |
| 133 | MAP2K6 | 0.16127439 |
| 134 | ROCK2 | 0.15395725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.20560807 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.95391762 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.82618702 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.70149514 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.68504007 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.54861562 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.52544377 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07695202 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.00266667 |
| 10 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.92223327 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.80993275 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70048984 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58835939 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56673007 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56226078 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46700117 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45180923 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37672757 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37204641 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35841681 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35338478 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.32437892 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31205948 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31179019 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31110873 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22971314 |
| 27 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22954835 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20389484 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.18953827 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.18340241 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15455119 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14182562 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13659137 |
| 34 | HTLV-I infection_Homo sapiens_hsa05166 | 1.13532691 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09783778 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08065537 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06711979 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.01606130 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 1.00521420 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 0.99565029 |
| 41 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98639946 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 0.97492952 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96624532 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95952848 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94432971 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92607064 |
| 47 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90425778 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90014505 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89105273 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88889937 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88614928 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.88275611 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88068957 |
| 54 | Malaria_Homo sapiens_hsa05144 | 0.85639455 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84891375 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84353549 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83689926 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80989030 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80247050 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79544271 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.79434056 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78935805 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73947889 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73760092 |
| 65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72195945 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71929972 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.69770724 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69523033 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68874432 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.68168462 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67874608 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.67829501 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67639281 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.66989217 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.66831047 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66536821 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65306660 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62918030 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61143285 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61049561 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60846933 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.60498549 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60426638 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58010221 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57786664 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57641575 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57228683 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55919451 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55626386 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54477110 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53711152 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53228098 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53180570 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52489352 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.52197511 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51648567 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51383872 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51084705 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50601760 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50564825 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50059890 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.49626770 |
| 103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49422689 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48928809 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48769753 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.48413493 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48104693 |
| 108 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47985383 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47320280 |
| 110 | Legionellosis_Homo sapiens_hsa05134 | 0.47152427 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.46819604 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44659207 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44617122 |
| 114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43622805 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.43616976 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42793465 |
| 117 | Morphine addiction_Homo sapiens_hsa05032 | 0.42071757 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40678575 |
| 119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.40669714 |
| 120 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40521742 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40389804 |
| 122 | Salivary secretion_Homo sapiens_hsa04970 | 0.40300168 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40261205 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39911224 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39836035 |
| 126 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39757508 |

